Polyrizon Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 2

Employees

  • Stock Symbol
  • PLRZ

Stock Symbol

  • Share Price
  • $10.72
  • (As of Tuesday Closing)

Polyrizon General Information

Description

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • HaTidhar Street 5
  • Raanana
  • Israel
+972
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • HaTidhar Street 5
  • Raanana
  • Israel
+972

Polyrizon Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Polyrizon Stock Performance

As of 17-Nov-2026, Polyrizon’s stock price is $10.72. Its current market cap is $25.9M with 2.43M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.72 $10.70 $2.88 - $18.20 $25.9M 2.43M 41.1K -$4.96

Polyrizon Financials Summary

As of 30-Jun-2026, Polyrizon has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 13,627 (6,984) 9,477
Revenue 0 0 0 0
EBITDA (7,998) (3,363) (1,427) (596)
Net Income (4,582) (3,335) (1,545) (600)
Total Assets 24,862 21,437 5,547 559
Total Debt 0 0 0 200
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Polyrizon Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Polyrizon‘s full profile, request access.

Request a free trial

Polyrizon Patents

Polyrizon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4395741-A1 Mucoadhesive polymers for nasal drug delivery Pending 31-Aug-2021
EP-4751737-A2 Mucoadhesive polymers for nasal drug delivery Pending 31-Aug-2021
EP-4751737-A3 Mucoadhesive polymers for nasal drug delivery Pending 31-Aug-2021
JP-2024532611-A Mucoadhesive polymers for nasal drug delivery Pending 31-Aug-2021
WO-2023031929-A1 Mucoadhesive polymers for nasal drug delivery Inactive 31-Aug-2021 A61K31/738
To view Polyrizon’s complete patent history, request access »

Polyrizon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Polyrizon ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Polyrizon’s complete esg history, request access »

Polyrizon FAQs

  • When was Polyrizon founded?

    Polyrizon was founded in 2005.

  • Where is Polyrizon headquartered?

    Polyrizon is headquartered in Raanana, Israel.

  • What is the size of Polyrizon?

    Polyrizon has 2 total employees.

  • What industry is Polyrizon in?

    Polyrizon’s primary industry is Drug Discovery.

  • Is Polyrizon a private or public company?

    Polyrizon is a Public company.

  • What is Polyrizon’s stock symbol?

    The ticker symbol for Polyrizon is PLRZ.

  • What is the current stock price of Polyrizon?

    As of 17-Nov-2026 the stock price of Polyrizon is $10.72.

  • What is the current market cap of Polyrizon?

    The current market capitalization of Polyrizon is $25.9M.

  • What is Polyrizon’s annual earnings per share (EPS)?

    Polyrizon’s EPS for 12 months was -$4.96.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process